SecSonar.com

Pacific Biosciences of California, Inc. (PACB)

Pacific Biosciences of California, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Pacific Biosciences of California, Inc. (PACB) is a Medical - Devices company based in US with a market capitalization of $469.2M. Revenue grew 3.9% year-over-year and free cash flow was negative at -$113.9M. This page tracks PACB's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 575 employees · IPO Oct 27, 2010

Valuation

Valuation & price

$1.12 · as of May 17, 2026 · -58.1% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

87.72

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$2.63$1.89$1.15Jul 25Dec 25Jul 26Jul 7, 25$1.47Jul 9, 25$1.48Jul 11, 25$1.47Jul 15, 25$1.44Jul 17, 25$1.39Jul 21, 25$1.45Jul 23, 25$1.69Jul 25, 25$1.54Jul 29, 25$1.54Jul 31, 25$1.38Aug 4, 25$1.39Aug 6, 25$1.38Aug 11, 25$1.26Aug 13, 25$1.28Aug 15, 25$1.31Aug 19, 25$1.30Aug 21, 25$1.26Aug 25, 25$1.32Aug 27, 25$1.33Aug 29, 25$1.31Sep 3, 25$1.26Sep 5, 25$1.27Sep 9, 25$1.31Sep 11, 25$1.26Sep 16, 25$1.23Sep 18, 25$1.28Sep 22, 25$1.29Sep 24, 25$1.25Sep 26, 25$1.21Sep 30, 25$1.28Oct 2, 25$1.43Oct 6, 25$1.52Oct 8, 25$1.51Oct 10, 25$1.42Oct 14, 25$1.59Oct 16, 25$1.76Oct 21, 25$1.90Oct 23, 25$1.95Oct 27, 25$2.09Oct 29, 25$2.01Oct 31, 25$2.34Nov 4, 25$2.00Nov 6, 25$1.78Nov 10, 25$1.76Nov 12, 25$1.74Nov 14, 25$1.61Nov 18, 25$1.65Nov 20, 25$1.88Nov 25, 25$2.63Nov 28, 25$2.32Dec 2, 25$2.32Dec 4, 25$2.52Dec 8, 25$2.32Dec 10, 25$2.37Dec 12, 25$2.12Dec 16, 25$2.02Dec 18, 25$1.88Dec 22, 25$1.82Dec 24, 25$1.88Dec 29, 25$1.71Jan 2, 26$1.84Jan 6, 26$2.08Jan 8, 26$2.04Jan 12, 26$2.01Jan 14, 26$2.36Jan 16, 26$2.21Jan 21, 26$2.42Jan 23, 26$2.58Jan 27, 26$2.57Jan 29, 26$2.37Feb 2, 26$2.06Feb 4, 26$1.95Feb 9, 26$1.84Feb 11, 26$1.84Feb 13, 26$1.71Feb 18, 26$1.63Feb 20, 26$1.61Feb 24, 26$1.66Feb 26, 26$1.78Mar 2, 26$1.62Mar 4, 26$1.56Mar 6, 26$1.38Mar 10, 26$1.37Mar 12, 26$1.27Mar 17, 26$1.38Mar 19, 26$1.40Mar 23, 26$1.39Mar 25, 26$1.39Mar 27, 26$1.26Mar 31, 26$1.32Apr 2, 26$1.34Apr 7, 26$1.44Apr 9, 26$1.35Apr 13, 26$1.45Apr 15, 26$1.60Apr 17, 26$1.69Apr 22, 26$1.71Apr 24, 26$1.56Apr 28, 26$1.58Apr 30, 26$1.59May 4, 26$1.55May 6, 26$1.71May 8, 26$1.41May 12, 26$1.28May 14, 26$1.21May 18, 26$1.15May 20, 26$1.19May 22, 26$1.22May 28, 26$1.47Jun 1, 26$1.58Jun 3, 26$1.58Jun 5, 26$1.45Jun 9, 26$1.37Jun 11, 26$1.35Jun 15, 26$1.32Jun 17, 26$1.34Jun 22, 26$1.32Jun 24, 26$1.44Jun 26, 26$1.65Jul 2, 26$1.68
$1.1252-week range$2.67
Loading valuation history…

Fundamentals

Key fundamentals

$469.2M

Market cap

3.9%

Revenue growth (YoY)

31.7%

Gross margin

-$113.9M

Free cash flow (USD)

$480M

Net debt

9.3%

Share dilution

0/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$90.7MFY 2017$93.5MFY 2018$78.6MFY 2019$90.9MFY 2020$78.9MFY 2021$130.5MFY 2022$128.3MFY 2023$200.5MFY 2024$154.0MFY 2025$160.0M
$90.7M$160M

Free cash flow by year

2016 → 2025

FY 2016$-76.1MFY 2017$-78.0MFY 2018$-68.3MFY 2019$-81.1MFY 2020$18.5MFY 2021$-117.1MFY 2022$-280.1MFY 2023$-275.4MFY 2024$-212.2MFY 2025$-113.9M
-$76.1M-$113.9M

Gross margin by year

2021 → 2025

FY 202145.1%FY 202238.2%FY 202326.3%FY 202424.2%FY 202531.7%
45.1%31.7%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 8, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventEquity Incentive Plan AmendedJun 4, 2026Filing
  • Quarterly report10-Q FiledMay 8, 2026Filing
  • 8-K eventEarnings ReleaseMay 7, 2026Filing
  • Insider sellInsider Sell $121KGibson James R II · See Remarks · $120.8KApr 3, 2026Filing

Questions

Frequently asked questions

What is Pacific Biosciences of California, Inc.'s market cap?

Pacific Biosciences of California, Inc. (PACB) has a market capitalization of $469.2M.

What is PACB's P/E ratio?

A meaningful P/E ratio is not available for PACB — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is PACB's price-to-book (P/B) ratio?

PACB trades at 87.72 times book value per share.

Are insiders buying PACB stock?

SEC Form 4 filings show no open-market insider buys at Pacific Biosciences of California, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Devices

LAB

Standard BioTools Inc.

$450.9M

KIDS

OrthoPediatrics Corp.

$449.3M

VREX

Varex Imaging Corporation

$434.5M

CTKB

Cytek Biosciences, Inc.

$551.6M

OFIX

Orthofix Medical Inc.

$382.1M

VMD

Viemed Healthcare, Inc.

$381.1M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.